BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35131871)

  • 1. The JAK3
    Lahera A; Vela-Martín L; Fernández-Navarro P; Llamas P; López-Lorenzo JL; Cornago J; Santos J; Fernández-Piqueras J; Villa-Morales M
    Mol Carcinog; 2024 Jan; 63(1):5-10. PubMed ID: 37712558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.
    Fregona V; Bayet M; Bouttier M; Largeaud L; Hamelle C; Jamrog LA; Prade N; Lagarde S; Hebrard S; Luquet I; Mansat-De Mas V; Nolla M; Pasquet M; Didier C; Khamlichi AA; Broccardo C; Delabesse É; Mancini SJC; Gerby B
    J Exp Med; 2024 Jan; 221(1):. PubMed ID: 37930337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
    Cobaleda C; Godley LA; Nichols KE; Wlodarski MW; Sanchez-Garcia I
    Cancer Discov; 2024 Mar; 14(3):396-405. PubMed ID: 38426560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from mouse models in the impact of risk factors on the genesis of childhood B-cell leukemia.
    Casado-García A; Isidro-Hernández M; Alemán-Arteaga S; Ruiz-Corzo B; Riesco S; Prieto-Matos P; Sánchez L; Sánchez-García I; Vicente-Dueñas C
    Front Immunol; 2023; 14():1285743. PubMed ID: 37901253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.
    Isidro-Hernández M; Casado-García A; Oak N; Alemán-Arteaga S; Ruiz-Corzo B; Martínez-Cano J; Mayado A; Sánchez EG; Blanco O; Gaspar ML; Orfao A; Alonso-López D; De Las Rivas J; Riesco S; Prieto-Matos P; González-Murillo Á; Criado FJG; Cenador MBG; Ramírez-Orellana M; de Andrés B; Vicente-Dueñas C; Cobaleda C; Nichols KE; Sánchez-García I
    Nat Commun; 2023 Aug; 14(1):5159. PubMed ID: 37620322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proof-of-principle: targeted childhood leukemia prevention.
    Cobaleda C; Ramírez-Orellana M; Vicente-Dueñas C; Weiss A; Nichols KE; Sánchez-García I
    Oncotarget; 2023 Mar; 14():190-192. PubMed ID: 36913308
    [No Abstract]   [Full Text] [Related]  

  • 7. Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190
    Qin R; Wang T; He W; Wei W; Liu S; Gao M; Huang Z
    Cell Commun Signal; 2023 Jan; 21(1):27. PubMed ID: 36721266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood B-Cell Preleukemia Mouse Modeling.
    Isidro-Hernández M; Alemán-Arteaga S; Casado-García A; Ruiz-Corzo B; Riesco S; Prieto-Matos P; Martínez-Cano J; Sánchez L; Cobaleda C; Sánchez-García I; Vicente-Dueñas C
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the prevention of childhood leukemia.
    Nichols KE; Sánchez-García I
    Oncoscience; 2022; 9():17-19. PubMed ID: 35479646
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
    Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
    J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust in vivo model for B cell precursor acute lymphoblastic leukemia.
    Fry TJ; Aplan PD
    J Clin Invest; 2015 Sep; 125(9):3427-9. PubMed ID: 26301807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility.
    Martín-Lorenzo A; Hauer J; Vicente-Dueñas C; Auer F; González-Herrero I; García-Ramírez I; Ginzel S; Thiele R; Constantinescu SN; Bartenhagen C; Dugas M; Gombert M; Schäfer D; Blanco O; Mayado A; Orfao A; Alonso-López D; Rivas Jde L; Cobaleda C; García-Cenador MB; García-Criado FJ; Sánchez-García I; Borkhardt A
    Cancer Discov; 2015 Dec; 5(12):1328-43. PubMed ID: 26408659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ruxolitinib in acute lymphoblastic leukemia: A systematic review.
    Kołodrubiec J; Kozłowska M; Irga-Jaworska N; Sędek Ł; Pastorczak A; Trelińska J; Młynarski W
    Leuk Res; 2022 Oct; 121():106925. PubMed ID: 35939887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice.
    Casado-García A; Isidro-Hernández M; Oak N; Mayado A; Mann-Ran C; Raboso-Gallego J; Alemán-Arteaga S; Buhles A; Sterker D; Sánchez EG; Martínez-Cano J; Blanco O; Orfao A; Alonso-López D; De Las Rivas J; Riesco S; Prieto-Matos P; González-Murillo Á; García Criado FJ; García Cenador MB; Radimerski T; Ramírez-Orellana M; Cobaleda C; Yang JJ; Vicente-Dueñas C; Weiss A; Nichols KE; Sánchez-García I
    Cancer Res; 2022 Mar; 82(6):1098-1109. PubMed ID: 35131871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
    Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
    Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.